Breaking: US Idiopathic Pulmonary Fibrosis Treatment Market Set to...

added blog Health

2026-07-03 09:00:16 -

Breaking: US Idiopathic Pulmonary Fibrosis Treatment Market Set to Reach $1.67 Billion by 2035

The US idiopathic pulmonary fibrosis treatment market is experiencing remarkable growth, projected to reach a staggering $1.67 billion by 2035. This growth trajectory is underscored by a compound annual growth rate (CAGR) of 6.73% from 2024 to 2035. As increased awareness and novel therapeutic approaches emerge, the treatment landscape for idiopathic pulmonary fibrosis (IPF) is evolving...

0 Comments 0 Shares 76 Views 0 Reviews